BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11270472)

  • 1. Parvovirus B19 antibodies in immunocompromized children in Thailand.
    Suandork P; Theamboonlers A; Likitnukul S; Hirsch P; Poovorawan Y
    Asian Pac J Allergy Immunol; 2000 Sep; 18(3):161-4. PubMed ID: 11270472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
    Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
    J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
    Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
    J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
    Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
    Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
    Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
    Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to parvovirus B 19 in Thailand.
    Poovorawan Y; Theamboonlers A; Suandork P; Hirsch P
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):422-4. PubMed ID: 11127352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
    Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 infection in Hong Kong.
    Lim WL; Wong KF; Lau CS
    J Infect; 1997 Nov; 35(3):247-9. PubMed ID: 9459396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
    Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
    J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent parvovirus B19 infections in immunocompromised children.
    Flunker G; Peters A; Wiersbitzky S; Modrow S; Seidel W
    Med Microbiol Immunol; 1998 Mar; 186(4):189-94. PubMed ID: 9574901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A seroepidemiologic study of human parvovirus B19 infection in children].
    Eiros Bouza JM; Bachiller Luque MR; Ochoa Sangrador C; Ortiz de Lejarazu R
    An Esp Pediatr; 1999 Jan; 50(1):101-2. PubMed ID: 10083659
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.
    Azadmanesh K; Mohraz M; Kazemimanesh M; Aghakhani A; Foroughi M; Banifazl M; Eslamifar A; Ramezani A
    J Med Virol; 2015 Jul; 87(7):1124-9. PubMed ID: 25771750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
    Zaki SA
    Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of human parvovirus B19 in Taiwan.
    Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
    J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy.
    El-Mahallawy HA; Mansour T; El-Din SE; Hafez M; Abd-el-Latif S
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):403-6. PubMed ID: 15218412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.